Starpharma Holdings reported AUD-1034000 in EBIT for its fiscal semester ending in December of 2023.


Ebit Change Date
Medical Developments International AUD -12124000 3.97M Jun/2023
Mesoblast -31307000 3.82M Jun/2024
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024